PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10933891-2	2000	We have studied the effects of two fibrates, bezafibrate and Wy-14,643, on UCP-3 and UCP-2 mRNA levels in primary monolayer cultures of rat adipocytes and undifferentiated preadipocytes.	Bezafibrate	45-56	uncoupling protein 3	Rattus norvegicus	75-80	
15356383-7	2004	On day 3 of BF administration, the levels of UCP2 mRNA expression in the skeletal muscles as well as UCP3 mRNA expression in the WAT were significantly increased in the high-dose BF group.	Bezafibrate	12-14	uncoupling protein 3	Rattus norvegicus	101-105	
15356383-7	2004	On day 3 of BF administration, the levels of UCP2 mRNA expression in the skeletal muscles as well as UCP3 mRNA expression in the WAT were significantly increased in the high-dose BF group.	Bezafibrate	179-181	uncoupling protein 3	Rattus norvegicus	101-105	
10933891-4	2000	Thus, bezafibrate treatment resulted in an 8-fold induction in UCP-3 mRNA levels in preadipocytes compared with the 3.5-fold induction observed in adipocytes.	Bezafibrate	6-17	uncoupling protein 3	Rattus norvegicus	63-68	
10933891-9	2000	Since it has been proposed that UCP-3 could be involved in the regulation of the use of fatty acids as fuel substrates, the UCP-3 induction achieved after bezafibrate and Wy-14, 643 treatment may indicate a higher oxidation of fatty acids, limiting their availability to be stored as triglycerides.	Bezafibrate	155-166	uncoupling protein 3	Rattus norvegicus	124-129	
10403804-0	1999	Uncoupling protein-3 mRNA levels are increased in white adipose tissue and skeletal muscle of bezafibrate-treated rats.	Bezafibrate	94-105	uncoupling protein 3	Rattus norvegicus	0-20